News

May 24, 2012

Niiki Pharma to Present Final Phase I Clinical Data on Anti-Cancer Agent at ASCO
Read more here

May 07, 2012

Galleon Pharmaceuticals Reports Positive Results from Phase I Study of GAL-021 For Treatment of Respiratory Depression
Read more here

Apr 06, 2012

FDA Approves Amyvid™ (Florbetapir F 18 Injection) for Use in Patients
Read more here

Apr 03, 2012

Niiki Pharma Presents Data on NKP-2235, the First Highly Orally Bioavailable Gallium-Based Anti-Cancer Agent
Read more here

Mar 28, 2012

Niiki Pharma to Present Preclinical Results, Start Testing Cancer Drug
Read more here

Mar 09, 2012

QR Pharma Has a Gut Feeling about Parkinson’s
Read more here

Mar 06, 2012

QR Pharma Awarded Funding by Michael J. Fox Foundation to Test Posiphen® as a Treatment for Parkinson’s Disease
Read more here

Feb 21, 2012

Ceptaris Secures $15M in Venture Debt Financing
Read more here

Feb 20, 2012

Firm Logs Instant Feedback on Doctor Visits
Read more here

Feb 07, 2012

CarePartners Plus® Launches Wellby® — A New Innovative Patient Engagement and Feedback Technology Tool
Read more here